Episode 304: A PSMA CD3 Bispecific T-cell Engager in CRPC
Release Date:
Tanya Dorff describes acapatamab, a prostate-specific membrane antigen (PSMA) CD3 bispecific engager.
Episode 304: A PSMA CD3 Bispecific T-cell Engager in CRPC
Tanya Dorff describes acapatamab, a prostate-specific membrane antigen (PSMA) CD3 bispecific engager.
Episode 304: A PSMA CD3 Bispecific T-cell Engager in CRPC